New drug cocktail targets Hard-to-Treat blood cancers
NCT ID NCT02328014
First seen Nov 01, 2025 · Last updated May 01, 2026 · Updated 25 times
Summary
This study tested a combination of two experimental drugs, acalabrutinib and ACP-319, in 40 people with B-cell blood cancers like non-Hodgkin lymphoma and multiple myeloma. The goal was to see if the combo is safe and shrinks tumors. Participants had to have a confirmed diagnosis and be well enough for treatment. The study is complete, but results are not yet public.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MULTIPLE MYELOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Research Site
Orange, California, 92868, United States
-
Research Site
Bethesda, Maryland, 20892, United States
-
Research Site
Rochester, New York, 14642, United States
-
Research Site
Portland, Oregon, 97239, United States
-
Research Site
Nashville, Tennessee, 37203, United States
-
Research Site
Austin, Texas, 78705, United States
-
Research Site
Seattle, Washington, 98109, United States
Conditions
Explore the condition pages connected to this study.